These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36208014)

  • 1. Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial module.
    Morfouace M; Hol MLF; Schoot RA; Slater O; Indelicato DJ; Kolb F; Smeele LE; Merks JHM; Rae C; Maurice-Stam H; Klassen AF; Grootenhuis MA
    Cancer Med; 2023 Feb; 12(4):4739-4750. PubMed ID: 36208014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcoma.
    Vaarwerk B; Schoot RA; Maurice-Stam H; Slater O; Hartley B; Saeed P; Gajdosova E; van den Brekel MW; Balm AJM; Hol MLF; van Jaarsveld S; Kremer LCM; Ronckers CM; Mandeville HC; Pieters BR; Gaze MN; Davila Fajardo R; Strackee SD; Dunaway D; Smeele LE; Chisholm JC; Caron HN; Grootenhuis MA; Merks JHM
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27498. PubMed ID: 30318743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment.
    Schoot RA; Slater O; Ronckers CM; Zwinderman AH; Balm AJ; Hartley B; van den Brekel MW; Gupta S; Saeed P; Gajdosova E; Pieters BR; Gaze MN; Mandeville HC; Fajardo RD; Chang YC; Gains JE; Strackee SD; Dunaway D; Abela C; Mason C; Smeele LE; Chisholm JC; Levitt GA; Kremer LC; Grootenhuis MA; Maurice-Stam H; Stiller CA; Hammond P; Caron HN; Merks JH
    Eur J Cancer; 2015 Jul; 51(11):1424-34. PubMed ID: 25998323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing loss in survivors of childhood head and neck rhabdomyosarcoma: a long-term follow-up study.
    Schoot RA; Theunissen EA; Slater O; Lopez-Yurda M; Zuur CL; Gaze MN; Chang YC; Mandeville HC; Gains JE; Rajput K; Pieters BR; Davila Fajardo R; Talwar R; Caron HN; Balm AJ; Dreschler WA; Merks JH
    Clin Otolaryngol; 2016 Jun; 41(3):276-83. PubMed ID: 26293165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
    Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
    Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
    Hol MLF; Indelicato DJ; Slater O; Kolb F; Hewitt RJ; Ong J; Becking AG; Gains J; Bradley J; Sandler E; Gaze MN; Pieters B; Mandeville H; Fajardo RD; Schoot R; Merks JHM; Hammond P; Smeele LE; Suttie M
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30412. PubMed ID: 37249325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial asymmetry in head and neck rhabdomyosarcoma survivors.
    Schoot RA; Hol MLF; Merks JHM; Suttie M; Slater O; van Lennep M; Hopman SMJ; Dunaway D; Syme-Grant J; Smeele LE; Zwinderman KH; Caron HN; Hammond P
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28423221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.
    Atkinson TM; Hay JL; Shoushtari A; Li Y; Paucar DJ; Smith SC; Kudchadkar RR; Doyle A; Sosman JA; Quevedo JF; Milhem MM; Joshua AM; Linette GP; Gajewski TF; Lutzky J; Lawson DH; Lao CD; Flynn PJ; Albertini MR; Sato T; Lewis K; Marr B; Abramson DH; Dickson MA; Schwartz GK; Carvajal RD
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):439-445. PubMed ID: 27921276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors.
    van Dijk IW; Cardous-Ubbink MC; van der Pal HJ; Heinen RC; van Leeuwen FE; Oldenburger F; van Os RM; Ronckers CM; Schouten-van Meeteren AY; Caron HN; Koning CC; Kremer LC
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):768-75. PubMed ID: 22954771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FACE-Q craniofacial module: Part 2 Psychometric properties of newly developed scales for children and young adults with facial conditions.
    Klassen AF; Rae C; Riff W; Denadai R; Murray DJ; Bracken S; Courtemanche DJ; Bulstrode N; O'Hara J; Butler D; Goldstein J; Tassi A; Hol ML; Johnson D; Ganske IM; Kölby L; Benitez S; Breuning EE; Malic CC; Allen GC; Pusic AL; Cano S
    J Plast Reconstr Aesthet Surg; 2021 Sep; 74(9):2330-2340. PubMed ID: 34172403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma.
    Diepstraten FA; Wiersma J; Schoot RA; Knops RRG; Zuur CL; Meijer AJM; Dávila Fajardo R; Pieters BR; Balgobind BV; Westerveld H; Freling N; van Tinteren H; Smeele LE; Bel A; van den Heuvel-Eibrink MM; Stokroos RJ; Merks JHM; Hoetink AE; Hol MLF
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
    Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM
    Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience.
    Estilo CL; Huryn JM; Kraus DH; Sklar CA; Wexler LH; Wolden SL; Zlotolow IM
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):215-22. PubMed ID: 12621240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Completing FACE-Q Craniofacial Module Scales on Children and Young Adults with Facial Differences: An International Study.
    Gallo L; Kamran R; Rae C; Deibert S; Voineskos SH; Wong Riff KWY; Klassen AF
    Plast Reconstr Surg; 2023 May; 151(5):1063-1069. PubMed ID: 36729090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
    Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
    JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa.
    Sineke T; Evans D; Schnippel K; van Aswegen H; Berhanu R; Musakwa N; Lönnmark E; Long L; Rosen S
    Health Qual Life Outcomes; 2019 May; 17(1):94. PubMed ID: 31151398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and functional outcome of male patients with bladder-prostate rhabdomyosarcoma treated with conservative surgery and brachytherapy during childhood.
    Martelli H; Borrego P; Guérin F; Boubnova J; Minard-Colin V; Dumas I; Chargari C; Haie-Meder C
    Brachytherapy; 2016; 15(3):306-311. PubMed ID: 26895712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Toxicities of Intensity-Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma.
    Lockney NA; Friedman DN; Wexler LH; Sklar CA; Casey DL; Wolden SL
    Pediatr Blood Cancer; 2016 Sep; 63(9):1608-14. PubMed ID: 27195454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dental and craniofacial alterations in long-term survivors of childhood head and neck rhabdomyosarcoma.
    Mattos VD; Ferman S; Magalhães DMA; Antunes HS; Lourenço SQC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2019 Apr; 127(4):272-281. PubMed ID: 30685390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.